Sutro Biopharma STRO Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's deferred tax assets and other non-current assets?
- Sutro Biopharma (STRO) reported deferred tax assets and other non-current assets of $1.09M in Q1 2026.
- How has Sutro Biopharma's deferred tax assets and other non-current assets changed year-over-year?
- Sutro Biopharma's deferred tax assets and other non-current assets increased by 1180.0% year-over-year, from $85K to $1.09M.
- What is the long-term trend for Sutro Biopharma's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Sutro Biopharma's deferred tax assets and other non-current assets has grown at a -25.3% compound annual growth rate (CAGR), from $2.12M to $495K.